OBJECTIVES: To investigate the metabolic syndrome and sex hormones in patients with Klinefelter's syndrome (KFS), 46XY men with nonobstructive azoospermia (NOA), and an age-matched obstructive azoospermia (OA) group. METHODS: We examined 60 patients with KFS, 60 46XY male patients with NOA, and 50 patients with OA. Height, weight, waist circumference, and blood pressure were examined. Fasting blood samples were analyzed for sex hormones, total cholesterol, high-density lipoprotein and low-density lipoprotein cholesterol, triglycerides, and plasma glucose. RESULTS: Height, weight, and waist circumferences were significantly greater in KFS patients compared with NOA and OA patients. Low-density lipoprotein cholesterol of KFS patients (132.9 +/- 29.4 mg/dL) was significantly increased compared with NOA (117.0 +/- 27.8 mg/dL) and OA patients (106.1 +/- 27.9 mg/dL) (P <0.05 and P <0.01). High-density lipoprotein cholesterol was significantly decreased in KFS patients (50.1 +/- 15.9 mg/dL) compared with NOA (58.7 +/- 11.7 mg/dL) and OA patients (59.5 +/- 17.9 mg/dL) (both P <0.05). Total cholesterol, triglycerides, and fasting glucose were not significantly different among the three groups. The differences between KFS and NOA, KFS and OA, and NOA and OA were all significant (P <0.01, P <0.001, and P <0.01, respectively) in terms of follicle-stimulating hormone, luteinizing hormone, and free testosterone level. CONCLUSIONS: Hypogonadism in KFS may cause an unfavorable change in body composition and the metabolic syndrome.
OBJECTIVES: To investigate the metabolic syndrome and sex hormones in patients with Klinefelter's syndrome (KFS), 46XY men with nonobstructive azoospermia (NOA), and an age-matched obstructive azoospermia (OA) group. METHODS: We examined 60 patients with KFS, 60 46XY male patients with NOA, and 50 patients with OA. Height, weight, waist circumference, and blood pressure were examined. Fasting blood samples were analyzed for sex hormones, total cholesterol, high-density lipoprotein and low-density lipoprotein cholesterol, triglycerides, and plasma glucose. RESULTS: Height, weight, and waist circumferences were significantly greater in KFSpatients compared with NOA and OA patients. Low-density lipoprotein cholesterol of KFSpatients (132.9 +/- 29.4 mg/dL) was significantly increased compared with NOA (117.0 +/- 27.8 mg/dL) and OA patients (106.1 +/- 27.9 mg/dL) (P <0.05 and P <0.01). High-density lipoprotein cholesterol was significantly decreased in KFSpatients (50.1 +/- 15.9 mg/dL) compared with NOA (58.7 +/- 11.7 mg/dL) and OA patients (59.5 +/- 17.9 mg/dL) (both P <0.05). Total cholesterol, triglycerides, and fasting glucose were not significantly different among the three groups. The differences between KFS and NOA, KFS and OA, and NOA and OA were all significant (P <0.01, P <0.001, and P <0.01, respectively) in terms of follicle-stimulating hormone, luteinizing hormone, and free testosterone level. CONCLUSIONS: Hypogonadism in KFS may cause an unfavorable change in body composition and the metabolic syndrome.
Authors: A F Radicioni; A Ferlin; G Balercia; D Pasquali; L Vignozzi; M Maggi; C Foresta; A Lenzi Journal: J Endocrinol Invest Date: 2010-12 Impact factor: 4.256
Authors: Simon Chang; Anne Skakkebaek; Shanlee M Davis; Claus H Gravholt Journal: Am J Med Genet C Semin Med Genet Date: 2020-06-04 Impact factor: 3.908
Authors: Andrea Salzano; Roberta D'Assante; Liam M Heaney; Federica Monaco; Giuseppe Rengo; Pietro Valente; Daniela Pasquali; Eduardo Bossone; Daniele Gianfrilli; Andrea Lenzi; Antonio Cittadini; Alberto M Marra; Raffaele Napoli Journal: Endocrine Date: 2018-03-23 Impact factor: 3.633
Authors: A E Calogero; V A Giagulli; L M Mongioì; V Triggiani; A F Radicioni; E A Jannini; D Pasquali Journal: J Endocrinol Invest Date: 2017-03-03 Impact factor: 4.256
Authors: Shanlee M Davis; Matthew G Cox-Martin; Martha Z Bardsley; Karen Kowal; Philip S Zeitler; Judith L Ross Journal: J Clin Endocrinol Metab Date: 2017-01-01 Impact factor: 5.958
Authors: Shanlee M Davis; Sophia DeKlotz; Kristen J Nadeau; Megan M Kelsey; Philip S Zeitler; Nicole R Tartaglia Journal: Am J Med Genet C Semin Med Genet Date: 2020-06-16 Impact factor: 3.908